These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 718136
1. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin. Elias SB, Appel SH. Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136 [Abstract] [Full Text] [Related]
2. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Plomp JJ, Van Kempen GT, De Baets MB, Graus YM, Kuks JB, Molenaar PC. Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358 [Abstract] [Full Text] [Related]
3. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases. Vincent A, Cull-Candy SG, Newsom-Davis J, Trautmann A, Molenaar PC, Polak RL. Muscle Nerve; 1981 May; 4(4):306-18. PubMed ID: 7254233 [Abstract] [Full Text] [Related]
4. Experimental autoimmune myasthenia gravis: the rabbit as an animal model. Eldefrawi ME. Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635 [Abstract] [Full Text] [Related]
5. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis. Claudio T, Raftery MA. J Supramol Struct; 1980 Dec; 14(3):267-79. PubMed ID: 6971372 [Abstract] [Full Text] [Related]
6. Effect of myasthenic IgG on degradation of junctional acetylcholine receptor. Takeo G, Motomura M, Mats H, Ohishi K, Yoshimura T, Tsujihata M, Nagataki S. Muscle Nerve; 1993 Aug; 16(8):840-8. PubMed ID: 8332137 [Abstract] [Full Text] [Related]
7. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)]. Takamori M, Ishii N, Tsujihata M, Mori M, Kasai M. No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200 [No Abstract] [Full Text] [Related]
9. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor. Vincent A, Newsom-Davis J. Adv Cytopharmacol; 1979 Jun; 3():269-78. PubMed ID: 474297 [No Abstract] [Full Text] [Related]
11. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction. Molenaar PC, Oen BS, Plomp JJ, Van Kempen GT, Jennekens FG, Hesselmans LF. Eur J Pharmacol; 1991 Apr 10; 196(1):93-101. PubMed ID: 1874282 [Abstract] [Full Text] [Related]
13. Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates. Cull-Candy SG, Miledi R, Uchitel OD. Nature; 1980 Jul 31; 286(5772):500-2. PubMed ID: 7402330 [No Abstract] [Full Text] [Related]
14. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor. Uchitel O, Engel AG, Walls TJ, Nagel A, Atassi MZ, Bril V. Muscle Nerve; 1993 Dec 31; 16(12):1293-301. PubMed ID: 8232384 [Abstract] [Full Text] [Related]
15. Interaction of di-iodinated 125I-labelled alpha-bungarotoxin and reversible cholinergic ligands with intact synaptic acetylcholine receptors on isolated skeletal-muscle fibres from the rat. Darveniza P, Morgan-Hughes JA, Thompson EJ. Biochem J; 1979 Sep 01; 181(3):545-57. PubMed ID: 518540 [Abstract] [Full Text] [Related]
19. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis. Carter B, Harrison R, Lunt GG, Morris H, Savage-Marengo T, Stephenson FA. Ann Clin Biochem; 1981 May 01; 18(Pt 3):146-52. PubMed ID: 7283364 [Abstract] [Full Text] [Related]
20. In vitro quantitative autoradiography of [125I]alpha-bungarotoxin binding at the motor end-plates of experimental autoimmune myasthenia gravis. Motomura M, Niwa M, Kataoka Y, Ootsuru I, Yoshimura T, Tsujihata M, Nagataki S. Neurosci Lett; 1992 Aug 31; 143(1-2):139-42. PubMed ID: 1436658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]